Perspectives of the European Association of Nuclear Medicine (EANM) on early perfusion imaging in the context of amyloid PET imaging protocols

Early perfusion amyloid-PET imaging is emerging as a valuable tool to potentially capture patients’ neurodegeneration patterns, allowing same-day, same-tracer categorization of both amyloidosis (A) and neurodegeneration (N) biomarkers. Early perfusion amyloid-PET might provide an added value for differential diagnosis and, in keeping with the capability of FDG-PET to indirectly track co-pathology in AD patients, it may complement the information provided by amyloid PET thus supporting a more accurate weighting of the different underlying pathological processes. Early perfusion imaging is, at the moment, still a research tool, as high-level evidence regarding a non-inferiority with respect to FDG-PET (especially in MCI patients) is still not available due to the lack of dedicated clinical trials. The present paper states the position of EANM on early perfusion imaging in the framework of dual-point amyloid-PET studies. The mounting evidence for its use, as well as unmet needs and potential cost-effectiveness, are summarized and discussed with the aim of paving the path for a proper recognition of its added value in the AT(N) system and in the clinical setting to further support differential diagnosis.

Authors

Institutions

Publication Details

Journal
The EANM Journal
Published
2025-09-23
DOI
https://doi.org/10.1016/j.eanmj.2025.100005
Citations
2
Primary Topic
Medical Imaging Techniques and Applications
Type
article
Field-Weighted Citation Impact
2.72
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Perspectives of the European Association of Nuclear Medicine (EANM) on early perfusion imaging in the context of amyloid PET imaging protocols

Eric Guedj, Tatjana Traub‐Weidinger, Pablo Aguiar Fernandez, Henryk Barthel et al.
2 citations
The EANM Journal
Medical Imaging Techniques and Applications
2.72
article

Perspectives of the European Association of Nuclear Medicine (EANM) on early perfusion imaging in the context of amyloid PET imaging protocols

Eric Guedj, Tatjana Traub‐Weidinger, Pablo Aguiar Fernandez, Henryk Barthel, Francesco Fraioli, Valentina Garibotto, Nathalie L. Albert, Diego Cecchin, Matthias Brendel, Igor Yakushev, Bart van Berckel, Donatienne Van Weehaeghe, Silvia Daniela Morbelli, Nelleke Tolboom, Antoine Verger
article en
2 citations

Abstract

Early perfusion amyloid-PET imaging is emerging as a valuable tool to potentially capture patients’ neurodegeneration patterns, allowing same-day, same-tracer categorization of both amyloidosis (A) and neurodegeneration (N) biomarkers. Early perfusion amyloid-PET might provide an added value for differential diagnosis and, in keeping with the capability of FDG-PET to indirectly track co-pathology in AD patients, it may complement the information provided by amyloid PET thus supporting a more accurate weighting of the different underlying pathological processes. Early perfusion imaging is, at the moment, still a research tool, as high-level evidence regarding a non-inferiority with respect to FDG-PET (especially in MCI patients) is still not available due to the lack of dedicated clinical trials. The present paper states the position of EANM on early perfusion imaging in the framework of dual-point amyloid-PET studies. The mounting evidence for its use, as well as unmet needs and potential cost-effectiveness, are summarized and discussed with the aim of paving the path for a proper recognition of its added value in the AT(N) system and in the clinical setting to further support differential diagnosis.

The EANM JournalVol. 1
University of Geneva (CH), Centre National de la Recherche Scientifique (FR), University of Padua (IT), Inserm (FR), Ghent University Hospital (BE), German Center for Neurodegenerative Diseases (DE), TUM Klinikum (DE), University Medical Center Utrecht (NL), Donauspital (AT), Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT), Städtisches Klinikum Dessau (DE), University Hospital of Geneva (CH), Amsterdam Neuroscience (NL), Munich Cluster for Systems Neurology (DE), Imagerie Adaptative Diagnostique et Interventionnelle (FR), Institut Fresnel (FR), Centre d'Imagerie BioMedicale (CH), Centrale Méditerranée (FR), University College London (GB), University of Turin (IT), Technical University of Munich (DE), Medical University of Vienna (AT), Ludwig-Maximilians-Universität München (DE), Vrije Universiteit Amsterdam (NL), Université de Lorraine (FR), Leipzig University (DE)
Openalex Percentile: Top 9%
Medical Imaging Techniques and Applications
2.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.